Partner Spotlight: Calla Lily Clinical Care

Calla Lily Clinical Care is transforming drug delivery for women through the development of their novel vaginal platform technology that improves both clinical outcomes and patient experience in women’s health. Their patented leak-free design allows for cleaner, more comfortable delivery of medicines and hormones, while also preventing drug wastage. Initial target indications are in fertility and pregnancy, where the company (a certified B Corp) seeks to offer the world’s first drug-device combination product for both threatened miscarriage and IVF luteal phase support. The platform’s versatility also makes it suitable for delivering a wide range of existing and upcoming vaginal therapeutics, including treatments for gynecological cancers, live biotherapeutic products (LBPs) to restore and maintain a healthy vaginal microbiome, and reducing the growth of antimicrobial resistance (AMR).

Calla Lily is currently seeking investment partners to help drive forward their important work in women's health. If interested please reach out via email to founders@callali.ly